Mural, a fintech startup that enables businesses to use unified accounts for both fiat currencies and stablecoins, has raised $15 million in a Series A funding round led by Tether, bringing its total funding to $28 million. The company, which rebranded from Mural Pay to Mural, has processed $2.1 billion in payments across 128 countries since launching its API in 2025, with rapid growth expected in 2026. Tether's investment highlights the demand for seamless, compliant money movement solutions. Mural plans to use the funds to expand globally, focusing on Latin America with a new country manager in Argentina.
Mural's recent $15 million Series A funding led by Tether comes as a backdrop to a broadly positive cryptocurrency market. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 21, 2026 03:41 WIB: out of 50 major cryptocurrencies, 45 rose and 4 fell today. Notable movers include MANA (Decentraland) at Rp1.569 with a 4.74% increase and Pluang order activity of 87% Sell / 13% Buy, XTZ (Tezos) at Rp5.654 up 4.65% with 67% Sell / 33% Buy, and BAT (Basic Attention Token) at Rp3.601 rising 4.63% with 84% Sell / 16% Buy.
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...
Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...
